Durand D - Search Results

1

Evidence that clearance of hepatitis C virus RNA after alpha-interferon therapy in dialysis patients is sustained after renal transplantation.

Kamar N, Toupance O, Buchler M, Sandres-Saune K, Izopet J, Durand D, Rostaing L. Kamar N, et al. Among authors: durand d. J Am Soc Nephrol. 2003 Aug;14(8):2092-8. doi: 10.1097/01.asn.0000079613.81511.3c. J Am Soc Nephrol. 2003. PMID: 12874463

2

Evolution of hepatitis C virus quasispecies in renal transplant patients with de novo glomerulonephritis.

Kamar N, Rostaing L, Boulestin A, Sandres K, Dubois M, Ribes D, Modesto A, Durand D, Izopet J. Kamar N, et al. Among authors: durand d. J Med Virol. 2003 Apr;69(4):482-8. doi: 10.1002/jmv.10335. J Med Virol. 2003. PMID: 12601755

3

Long-term ribavirin therapy in hepatitis C virus-positive renal transplant patients: effects on renal function and liver histology.

Kamar N, Sandres-Saune K, Selves J, Ribes D, Cointault O, Durand D, Izopet J, Rostaing L. Kamar N, et al. Among authors: durand d. Am J Kidney Dis. 2003 Jul;42(1):184-92. doi: 10.1016/s0272-6386(03)00422-0. Am J Kidney Dis. 2003. PMID: 12830471 Clinical Trial.

4

Amantadine therapy in renal transplant patients with hepatitis C virus infection.

Kamar N, Rostaing L, Sandres-Saune K, Ribes D, Durand D, Izopet J. Kamar N, et al. Among authors: durand d. J Clin Virol. 2004 May;30(1):110-4. doi: 10.1016/j.jcv.2003.10.001. J Clin Virol. 2004. PMID: 15072764 Clinical Trial.

5

Effects of long-term lamivudine therapy in renal-transplant patients.

Kamar N, Sandres-Saune K, Ribes D, Duffaut M, Selves J, Durand D, Izopet J, Rostaing L. Kamar N, et al. Among authors: durand d. J Clin Virol. 2004 Dec;31(4):298-303. doi: 10.1016/j.jcv.2004.07.001. J Clin Virol. 2004. PMID: 15494273

6

Induction therapy with either anti-CD25 monoclonal antibodies or rabbit antithymocyte globulins in liver transplantation for hepatitis C.

Kamar N, Borde JS, Sandres-Saune K, Suc B, Barange K, Cointault O, Lavayssière L, Durand D, Izopet J, Rostaing L. Kamar N, et al. Among authors: durand d. Clin Transplant. 2005 Feb;19(1):83-9. doi: 10.1111/j.1399-0012.2004.00302.x. Clin Transplant. 2005. PMID: 15659139

7

Acute hepatitis and renal function impairment related to infection by hepatitis E virus in a renal allograft recipient.

Kamar N, Mansuy JM, Esposito L, Legrand-Abravanel F, Peron JM, Durand D, Rostaing L, Izopet J. Kamar N, et al. Among authors: durand d. Am J Kidney Dis. 2005 Jan;45(1):193-6. doi: 10.1053/j.ajkd.2004.09.006. Am J Kidney Dis. 2005. PMID: 15696460

8

Follow-up of 28 HCMV seropositive renal-transplant recipients: comparison of clinical, biological and virological parameters in the groups of treated versus untreated infected patients.

Kamar N, Mengelle C, Yahyaoui S, Sandres-Sauné K, Durand D, Izopet J, Rostaing L. Kamar N, et al. Among authors: durand d. J Clin Virol. 2005 May;33(1):35-42. doi: 10.1016/j.jcv.2004.09.028. J Clin Virol. 2005. PMID: 15797363

9

Natural history of hepatitis C virus-related liver fibrosis after renal transplantation.

Kamar N, Rostaing L, Selves J, Sandres-Saune K, Alric L, Durand D, Izopet J. Kamar N, et al. Among authors: durand d. Am J Transplant. 2005 Jul;5(7):1704-12. doi: 10.1111/j.1600-6143.2005.00918.x. Am J Transplant. 2005. PMID: 15943629 Free article.

10

Intrahepatic cytokine profile in renal-transplant patients infected by hepatitis C virus.

Kamar N, Rostaing L, Sandres-Saune K, Selves J, Barthe C, Dubois M, Alric L, Durand D, Izopet J. Kamar N, et al. Among authors: durand d. J Med Virol. 2005 Aug;76(4):482-8. doi: 10.1002/jmv.20387. J Med Virol. 2005. PMID: 15977245

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,214 results

Search Page

Filters